GETINGE Total Long Term Liabilities 2016-2024 | GNGBY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GETINGE total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GETINGE total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$160.9B
Elevance Health (ELV)	$91.8B
Cencora (COR)	$49.1B
Natera (NTRA)	$23.4B
DiDi Global (DIDIY)	$22.6B
ICON (ICLR)	$16.4B
Revvity (RVTY)	$15.4B
Avantor (AVTR)	$15.2B
BioMerieux (BMXMF)	$14.4B
Viatris (VTRS)	$13.5B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.8B
Doximity (DOCS)	$11B
Medpace Holdings (MEDP)	$10.9B
EUROFINS SCIENT (ERFSF)	$10.4B
HealthEquity (HQY)	$9.6B
Charles River Laboratories (CRL)	$8.4B
Sonic Healthcare (SKHHY)	$8.3B
Amplifon S.p.A (AMFPF)	$6.1B
Bausch + Lomb (BLCO)	$6.1B
BrightSpring Health Services (BTSG)	$4.1B
Organon (OGN)	$4B
Sotera Health (SHC)	$3.9B
Surgery Partners (SGRY)	$3.2B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$3B
PACS (PACS)	$2.2B
Premier (PINC)	$2.2B
Ardent Health Partners (ARDT)	$2.1B
GeneDx Holdings (WGS)	$2.1B